Naltrexone can cause insomnia, and the effect is more than anecdotal. A systematic review with meta-analysis pooling data from over 500 people found that naltrexone roughly doubles the odds of insomnia compared to placebo. But the relationship between naltrexone and sleep is not straightforward: the same medication can also cause daytime drowsiness, and for some people it actually improves sleep. The reason involves a surprisingly tangled connection between your body’s opioid system and the hormones that regulate your sleep-wake cycle.
How Common Is Naltrexone-Related Insomnia
The best quantitative estimate comes from a meta-analysis published in Frontiers in Pharmacology that pooled results from randomized controlled trials of naltrexone in people being treated for alcohol use disorder. Across 514 individuals, naltrexone was associated with about twice the odds of insomnia compared to placebo, a statistically significant difference. The analysis found essentially no variation between the trials, meaning the effect was consistent rather than driven by one outlier study.1Frontiers in Pharmacology. Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis
A doubling of odds sounds alarming, but context matters. The baseline rate of insomnia in the placebo groups was not enormous, so doubling a modest number still means a minority of naltrexone users are affected. Many people take naltrexone without any noticeable change in their sleep. Still, if you are someone prone to sleep difficulties, that doubled risk is worth knowing about before you start the medication.
It Can Cause Daytime Drowsiness Too
Here is where the story gets strange. The same meta-analysis that found doubled insomnia risk also found that naltrexone significantly increased daytime sleepiness, with about 85 percent higher odds of somnolence compared to placebo across 529 individuals.1Frontiers in Pharmacology. Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis So naltrexone can keep you awake at night and make you drowsy during the day, sometimes in the same person.
This dual effect catches many people off guard, because most medications lean clearly one direction or the other. The explanation likely has to do with how naltrexone interacts with your body’s circadian rhythm rather than simply being a stimulant or sedative. It does not push you toward wakefulness or sleep in a simple way. Instead, it seems to disrupt the timing of sleep-related processes, which can manifest as nighttime restlessness and daytime sluggishness depending on when those processes are thrown off.
The Opioid-Melatonin Connection
To understand why blocking opioid receptors would mess with sleep, you need to know that your body’s endogenous opioid system and melatonin are deeply intertwined. Melatonin, the hormone that signals nighttime to your brain, does not operate in isolation. Research has shown that the opioid system modulates melatonin secretion from the pineal gland, and that some of melatonin’s downstream effects on the body actually require opioid system participation.2PubMed. The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man
Naltrexone works by blocking mu-opioid receptors. Those same receptors are involved in the day-night rhythm of pain perception and sleep regulation. Research into pineal opioid receptors has shown that melatonin has both analgesic and sleep-promoting properties that follow a circadian pattern, with high blood levels at night and low levels during the day. Critically, mu-opioid receptor antagonists (the class naltrexone belongs to) have been shown to disrupt this day-night rhythm.3PubMed. Pineal opioid receptors and analgesic action of melatonin
In practical terms, this means naltrexone may partly interfere with the normal nighttime surge of melatonin or blunt its effects on sleep architecture. The opioid system and melatonin engage in a kind of cross-talk: melatonin can reduce some hormonal changes caused by opioid antagonists, and opioid antagonists can block some of melatonin’s hormonal effects.2PubMed. The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man When you put a long-acting opioid blocker into this system and leave it there for hours, you are disrupting a conversation between two systems that normally coordinate to help you fall asleep and stay asleep.
Your Genetics May Determine Whether You Are Affected
Not everyone on naltrexone develops insomnia, and genetics appears to play a role in who does. Research on the mu-opioid receptor gene (OPRM1) has found that specific genetic variations in this gene are significantly associated with insomnia as a side effect of opioid-system medications. The association was particularly strong among individuals who were not using sedative-hypnotic medications (like benzodiazepines) that would mask the effect.4ScienceDirect (European Neuropsychopharmacology). Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients
This finding is from a cohort of patients on methadone maintenance therapy rather than naltrexone specifically, but the principle is relevant because both drugs act on the same receptor system. The implication is that the mu-opioid receptor varies from person to person in ways that affect how sensitive your sleep system is to disruption by anything that blocks or modulates those receptors. If you carry certain variants, you may be more likely to experience sleep disturbances. If you do not, you may sail through naltrexone treatment without any sleep issues. There is no widely available clinical test for this yet, but it helps explain why two people on the same dose can have completely different sleep experiences.
When Naltrexone Might Actually Improve Sleep
The insomnia finding, while statistically real, does not apply to every context. A study examining chronic sleep patterns in people treated with naltrexone for addiction found something unexpected: compared to both a methadone group and untreated controls, the naltrexone group had the shortest time to fall asleep and the longest total sleep time.5SpringerLink / European Archives of Psychiatry and Clinical Neuroscience. Effects of chronic treatment with methadone and naltrexone on sleep in addicts
This seems to contradict the insomnia data, but the populations are different. The meta-analysis showing doubled insomnia risk drew from trials of people being treated for alcohol dependence. The study showing improved sleep examined people treated for opioid addiction. In the latter group, ongoing opioid withdrawal and the disrupted sleep that comes with addiction recovery may mean that naltrexone’s stabilizing effect on the opioid system ultimately helps normalize sleep, even if it causes some short-term disruption. The underlying condition being treated changes the equation substantially.
Alcohol itself is notorious for degrading sleep quality even as it makes people feel drowsy, so people coming off alcohol may already have a disrupted sleep architecture that naltrexone does not help repair. People recovering from opioid addiction, by contrast, may find that having a stable opioid receptor blockade reduces the chaotic neurochemical swings of withdrawal and lets their sleep settle into a more normal pattern over time.
Low-Dose Naltrexone and Sleep
A growing number of people take naltrexone at doses far below the standard 50 mg, typically around 1.5 to 4.5 mg, for off-label uses like chronic pain and autoimmune conditions. This low-dose naltrexone (LDN) regimen has its own relationship with sleep. LDN is commonly given about an hour before bedtime, which reflects the idea that its brief, low-level opioid blockade triggers a rebound increase in endorphin production overnight.6PubMed Central. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
Even at these lower doses, some individuals report insomnia. The standard clinical response is to switch from bedtime to morning dosing, which often resolves the problem.6PubMed Central. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain This simple timing change works for many LDN users because the drug’s half-life at low doses means its effects have largely worn off by the time you go to bed if you take it in the morning. At a standard 50 mg dose, this strategy is less practical since the drug remains active much longer, but the principle of paying attention to dosing time still applies.
In fibromyalgia research, sleep quality has been measured as a specific outcome in LDN studies, using validated tools like the Insomnia Severity Index, suggesting that researchers in this field recognize sleep disruption as a meaningful concern worth tracking even at low doses.7PubMed Central. The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review The evidence on whether LDN ultimately helps or hinders sleep in fibromyalgia patients is still developing, but the fact that insomnia is tracked as a distinct variable tells you that clinicians consider it a real, expected possibility.
Practical Steps for Managing Naltrexone-Related Sleep Problems
If you are on naltrexone and struggling to sleep, the most evidence-supported approaches involve adjusting when and how you take the medication rather than adding more drugs to counteract it.
- Shift dosing time: If you take naltrexone in the evening, try moving it to the morning. This is well-documented as helpful for LDN users and may apply at standard doses too, though the longer duration of action at 50 mg means the benefit is less dramatic.
- Give it time: Many side effects of naltrexone, including sleep disturbance, are most pronounced in the first few weeks and diminish as your body adjusts. Clinicians often recommend waiting at least two to four weeks before concluding that the sleep disruption is permanent.
- Address the underlying condition’s sleep effects: If you are taking naltrexone for alcohol use disorder, the sleep problems you notice may partly reflect your brain recovering from alcohol’s effects on sleep architecture, not naltrexone alone. Alcohol suppresses REM sleep and creates a rebound effect during early sobriety that produces vivid dreams, fragmented sleep, and early-morning awakening regardless of what medication you are on.
- Consider sleep hygiene basics: This sounds generic, but it matters more on naltrexone because the medication may be nudging your circadian clock. Consistent wake times, limiting evening screen exposure, and avoiding caffeine after midday can partially compensate for the disruption naltrexone may impose on your melatonin rhythm.
- Talk to your prescriber about melatonin: Given the mechanistic link between naltrexone’s opioid blockade and melatonin signaling, supplemental melatonin is a plausible compensatory strategy. Some clinicians recommend it, though rigorous trial data specifically testing melatonin as a fix for naltrexone-induced insomnia are limited. The logic is sound based on what we know about the opioid-melatonin interaction, but this is an area where the clinical evidence has not yet caught up with the pharmacological rationale.
Vivid Dreams and Nighttime Disturbances
Beyond straightforward insomnia, many naltrexone users report unusually vivid or disturbing dreams. This is one of those side effects that shows up frequently in patient forums and clinical conversations but is harder to capture in formal studies because dream vividness is subjective and not routinely measured. The likely mechanism relates to naltrexone’s effects on sleep architecture. Opioid system activity helps regulate transitions between sleep stages, and blocking opioid receptors can shift the balance between lighter and deeper sleep phases, potentially increasing time in REM sleep, the stage where vivid dreaming occurs.
For some people, vivid dreams are the actual reason they cannot sleep well on naltrexone, because the dreams are disturbing enough to cause awakenings or anxiety about going to bed. If this describes your experience, it is worth mentioning to your prescriber because the management approach may differ from someone who simply cannot fall asleep. Timing adjustments and short-term sleep aids may be more relevant than standard insomnia strategies like sleep restriction therapy.
How the Injectable Form Compares
Naltrexone comes in both an oral tablet (taken daily) and a long-acting injectable form (given monthly). The injectable delivers a steady level of the drug over about four weeks, which eliminates the daily peaks and troughs that oral dosing produces. In theory, this could reduce sleep disruption because the brain is not experiencing a new wave of opioid blockade each day. In practice, though, the injectable also means you cannot simply adjust your dosing time to avoid nighttime effects, and you cannot stop the medication quickly if side effects become intolerable. If you are considering the injectable and sleep is a concern, it makes sense to start with the oral version first to see how you respond before committing to a month-long formulation.
The steady-state blood levels from the injectable might work in your favor if the sleep disruption from oral naltrexone is mainly driven by the initial post-dose spike in receptor blockade. But if your sleep issues are driven by the chronic presence of opioid blockade itself, the injectable would not help and could make things worse since you cannot take a break from it.
When the Condition Being Treated Matters More Than the Side Effect
For people taking naltrexone for alcohol or opioid use disorder, the risk-benefit calculation around insomnia deserves some honest perspective. Untreated alcohol dependence devastates sleep far more thoroughly than naltrexone does. Chronic heavy drinking fragments sleep architecture, suppresses restorative sleep stages, and creates a vicious cycle where people drink to fall asleep, sleep poorly anyway, and feel exhausted the next day. Naltrexone may modestly increase insomnia risk, but the alternative of continued drinking or relapse would likely be worse for sleep by a wide margin.
Similarly, opioid use disorder involves dramatic sleep disruption during withdrawal and ongoing instability during active use. The study that found naltrexone users had the shortest time to fall asleep and the longest total sleep time in that population is a reminder that the net effect of naltrexone on your sleep depends heavily on what your sleep looked like before treatment.5SpringerLink / European Archives of Psychiatry and Clinical Neuroscience. Effects of chronic treatment with methadone and naltrexone on sleep in addicts Stopping a medication that is helping you stay sober because it costs you an hour of sleep per night is a trade most clinicians would advise against. The better path is to manage the insomnia directly while continuing the treatment that is keeping you alive and functioning.